Search peptides, terms, sources/
Research source · 2026

Mazdutide versus placebo in Chinese adults with type 2 diabetes

About this source

Kind
Research
Design
Human clinical trial, RCT
Population
320 Chinese adults with type 2 diabetes inadequately controlled by diet and exercise alone
Sample size
320
Primary or secondary
primary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 November 2026

Limitations

Chinese population, mazdutide alone, 24-week placebo-controlled period. Funded by Innovent Biologics. Abstract read via Europe PMC; full text not read.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.